The current pregnant women living with hiv antiretroviral therapy coverage for pmtct in Guyana is 87%, which has increased by 17% (24.3%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Guyana
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Guyana
Male unintentional poisoning
0.0
-0.0
(2021)
Female wasting in children
5.6%
-0.6%
(2019)
Female prevalence of HIV
0.4%
+0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar284
-intl dollar33
(2022)
Birth registration
98.1%
+9.4%
(2020)
Contraceptive modern method prevalence
28.6%
-4%
(2020)
Guyana PMTCT antiretroviral therapy coverage between 2000 and 2022
Period | Value | Change |
---|---|---|
2022 | 87% | +17% |
2021 | 70% | +20% |
2020 | 50% | -14% |
2019 | 64% | +7% |
2018 | 57% | +9% |
2017 | 48% | -11% |
2016 | 59% | -3% |
2015 | 62% | +5% |
2014 | 57% | -13% |
2013 | 70% | +16% |
2012 | 54% | +4% |
2011 | 50% | +11% |
2010 | 39% | -21% |
2009 | 60% | +9% |
2008 | 51% | +9% |
2007 | 42% | +11% |
2006 | 31% | -11% |
2005 | 42% | +13% |
2004 | 29% | +6% |
2003 | 23% | +3% |
2002 | 20% | +20% |
2001 | 0% | 0% |
2000 | 0% |